-
The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic
30 Aug 2018 08:03 GMT
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling the Peaks
(Biotech Stocks hitting 52-week highs on Aug. 27)
Abbott Laboratories (NYSE: ABT)
Ascendis Pharma A/S (NASDAQ: ASND)
AtriCure Inc. (NASDAQ: ATRC)
…
-
Endocyte, Now Included In IBB, Has A Strong Clinical-Stage Asset
31 Jan 2018 20:18 GMT
… decided to examine Endocyte first. Why Endocyte turned up positive … , $ millions notes ECYT Endocyte, Inc. 153 cancer … Tetraphase Pharmaceuticals, Inc 315 antibiotics submitted to FDA Of … Genetics (SGEN).
Source: endocyte.com
Endocyte's Phase 3 …
-
Global Oncology Radiopharmaceuticals Market to Surpass US$ 5,206.8 Million by 2028, Says Coherent Market Insights (CMI)
27 Jan 2022 13:30 GMT
… company announced the acquisition of Endocyte. Endocyte is a biopharmaceutical company focused … Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, and Others), Cytokines, and Peptide …
-
Entasis Therapeutics Appoints David Meek as Chairman of the Board
24 Jun 2019 12:00 GMT
… , he held executive positions at Endocyte and Novartis. Mr. Meek began … develop a novel class of antibiotics, non-β-lactam inhibitors of the …
-
Tetraphase Pharmaceuticals Trial Failure May Mask Value
27 Feb 2018 20:12 GMT
… clinical-stage biotechnology company developing antibiotics. New antibiotics are needed because some … capitalization, $ millions notes (ECYT) Endocyte, Inc. 153 cancer & … to treat respiratory disease caused antibiotic-resistant bacteria, and pathogens …
-
Biotech Forum Daily Digest For March 12th
12 Mar 2018 15:13 GMT
… I deficiency on Monday.
Endocyte (ECYT) was initiated as … resistance has rendered these antibiotics less effective. Achaogen’s … typical for this preferred antibiotic. By contrast, plazomicin … the Medicines Company’s antibiotic portfolio to Melinta Therapeutics …
-
Reata Pharmaceuticals A Buy On Bardoxolene Data
14 Feb 2018 21:28 GMT
… stock from my screen in Endocyte, Now Included In IBB, Has … capitalization, $ millions notes (ECYT) Endocyte, Inc. 153 cancer & inflammation … (TTPH) Tetraphase Pharmaceuticals, Inc 315 antibiotics submitted to FDA Details are …
-
Syndax Pharmaceuticals Undervalued On Coming Data Readouts
15 Feb 2018 19:11 GMT
… Capitalization, $ Millions Notes (ECYT) Endocyte, Inc. 153 cancer & inflammation … (TTPH) Tetraphase Pharmaceuticals, Inc. 315 antibiotics submitted to FDA Lead candidate …
-
North America Drug Delivery devices market – estimated to reach USD 599.94 billion by 2021
20 Jul 2017 16:19 GMT
… formulations such as insulin and antibiotics are administered through drug delivery … the market are Bend Research, Endocyte, Microchips Inc, Pearl Therapeutics Inc …
-
Global Drug Delivery devices market – estimated to reach USD 1,495.31 Billion by 2021
04 Jul 2017 18:09 GMT
… formulations such as insulin and antibiotics are administered through drug delivery … the market are Bend Research, Endocyte, Microchips Inc, Pearl Therapeutics Inc …
About
© 1995-2025